Literature DB >> 12814180

Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis.

S Di Legge1, M C Piattella, C Pozzilli, P Pantano, F Caramia, I F Pestalozza, A Paolillo, G L Lenzi.   

Abstract

We investigated the relationship between emotional changes, brain lesion burden and development of multiple sclerosis (MS). Thirty-seven consecutive patients with clinically isolated syndrome (CIS) were prospectively assessed with the Expanded Disability Status Scale (EDSS), the 21-item Beck Depression Inventory (BDI), the State-Trait Anxiety Inventory (STAI) and gadolinium enhanced (Gd+) MRI scans. BDI and STAI were also administered to 36 age-matched controls. Conversion to MS was defined as the occurrence of a clinical relapse. CIS patients were more likely to endorse symptoms of anxiety and depression than controls. Baseline scores for depression and anxiety did not correlate with the total lesion load (i.e., volume of Gd+, T2 and T1 lesions) and the number of Gd+ lesions during the first six months of follow-up. A positive correlation was found between severity of depressive scores and the lesion load in the right temporal region (P = 0.005). After 33+/-6 months of the study entry, patients who had a clinical relapse were more frequently depressed (P = 0.001) than those relapse free. Emotional disturbances are frequently observed in CIS patients and show a tendency towards a normalization in relapse-free patients. The increased rate of depressive symptoms observed in patients who developed MS seems to result from a combination of psychological and organic features. The lesion load in the right temporal region is confirmed as a key area for developing depressive symptoms, even in the early phase of the disease.

Entities:  

Mesh:

Year:  2003        PMID: 12814180     DOI: 10.1191/1352458503ms921oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  9 in total

1.  Criteria improving multiple sclerosis diagnosis at the first MRI.

Authors:  Nathalie Caucheteux; Adil Maarouf; Margaux Genevray; Emmanuelle Leray; Romain Deschamps; Marie P Chaunu; Laure Daelman; Jean C Ferré; Olivier Gout; Jean Pelletier; Laurent Pierot; Gilles Edan; Ayman Tourbah
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

Review 2.  Psychiatric disorders in multiple sclerosis.

Authors:  Maddalena Sparaco; Luigi Lavorgna; Simona Bonavita
Journal:  J Neurol       Date:  2019-06-13       Impact factor: 4.849

3.  Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort.

Authors:  Vito Fiore; Andrea De Vito; Chiara Fanelli; Nicholas Geremia; Elija Princic; Alessandra Nivoli; Ivana Maida; Liliana Lorettu; Giordano Madeddu; Sergio Babudieri
Journal:  Med Princ Pract       Date:  2021-09-28       Impact factor: 1.927

4.  Neuropsychological deficits but not coping strategies are related to physical disability in multiple sclerosis.

Authors:  Claus G Haase; Marc Lienemann; Pedro M Faustmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

5.  Prospective examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosis.

Authors:  Michelle Nicole Burns; Ewa Nawacki; Juned Siddique; Daniel Pelletier; David C Mohr
Journal:  Psychosom Med       Date:  2012-11-28       Impact factor: 4.312

6.  Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome.

Authors:  Eva Hyncicova; Adam Kalina; Martin Vyhnalek; Tomas Nikolai; Lukas Martinkovic; Jiri Lisy; Jakub Hort; Eva Meluzinova; Jan Laczó
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

Review 7.  Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Carole Lunny; Jennifer A Knopp-Sihota; Shawn N Fraser
Journal:  BMC Neurol       Date:  2013-05-06       Impact factor: 2.474

8.  The neuroanatomical correlates of anxiety in a healthy population: differences between the State-Trait Anxiety Inventory and the Hamilton Anxiety Rating Scale.

Authors:  Giulia Donzuso; Antonio Cerasa; Maria C Gioia; Manuela Caracciolo; Aldo Quattrone
Journal:  Brain Behav       Date:  2014-06-18       Impact factor: 2.708

Review 9.  Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis.

Authors:  Antonio Bruno; Ettore Dolcetti; Francesca Romana Rizzo; Diego Fresegna; Alessandra Musella; Antonietta Gentile; Francesca De Vito; Silvia Caioli; Livia Guadalupi; Silvia Bullitta; Valentina Vanni; Sara Balletta; Krizia Sanna; Fabio Buttari; Mario Stampanoni Bassi; Diego Centonze; Georgia Mandolesi
Journal:  Front Cell Neurosci       Date:  2020-06-23       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.